These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6871869)
1. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A. Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869 [TBL] [Abstract][Full Text] [Related]
2. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection. Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870 [TBL] [Abstract][Full Text] [Related]
3. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell. Miller SC; Codington JF; Klein G J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278 [TBL] [Abstract][Full Text] [Related]
4. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma. Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825 [TBL] [Abstract][Full Text] [Related]
5. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth. Cooper AG; Codington JF; Miller DK; Brown MC J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714 [TBL] [Abstract][Full Text] [Related]
6. Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids. Codington JF; Klein G; Cooper AG; Lee N; Brown MC; Jeanloz RW J Natl Cancer Inst; 1978 Apr; 60(4):811-8. PubMed ID: 633390 [TBL] [Abstract][Full Text] [Related]
7. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics. Friberg S J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958 [No Abstract] [Full Text] [Related]
8. Site dependency of TA3 Ha allotransplantability. Hagmar B; Ryd W Transplantation; 1977 Jan; 23(1):93-7. PubMed ID: 835167 [TBL] [Abstract][Full Text] [Related]
9. Concanavalin A and other lectins in the study of tumor cell surface organization. Friberg S; Hammarström S Adv Exp Med Biol; 1975; 55():245-60. PubMed ID: 1098413 [TBL] [Abstract][Full Text] [Related]
10. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice. Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191 [TBL] [Abstract][Full Text] [Related]
11. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses. Springer GF; Desai PR Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544 [TBL] [Abstract][Full Text] [Related]
12. Ultrastructural and histochemical differences in cell surface properties of strain-specific and nonstrain-specific TA3 adenocarcinoma cells. Miller SC; Hay ED; Codington JF J Cell Biol; 1977 Mar; 72(3):511-29. PubMed ID: 838766 [TBL] [Abstract][Full Text] [Related]
13. Transplantability and antigenicity of two sublines of the TA3 tumor. Sanford BH; Codington JF; Jeanloz RW; Palmer PD J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632 [No Abstract] [Full Text] [Related]
14. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells. Lippman MM; Venditti JM; Kline I; Elam DL Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468 [No Abstract] [Full Text] [Related]
15. Comparative lectin-binding and agglutination properties of the strain-specific, TA-3-St, and the non-strain-specific, TA3-Ha, murine mammary carcinoma ascites sublines. Further studies of receptors in epiglycanin. Matsumoto I; Codington JF; Jahnke MR; Jeanloz RW; Osawa T Carbohydr Res; 1980 Apr; 80(1):179-89. PubMed ID: 7363275 [TBL] [Abstract][Full Text] [Related]
16. Two kinds of antigen suppression in tumor cells revealed by cell fusion. Klein G; Friberg S; Harris H J Exp Med; 1972 Apr; 135(4):839-49. PubMed ID: 5018053 [TBL] [Abstract][Full Text] [Related]
17. Effects of retinoic acid on ascites cells of the TA3 mouse mammary carcinoma. Walker-Nasir E; Codington JF; Lampert LA; Jeanloz RW Experientia; 1985 Mar; 41(3):402-4. PubMed ID: 2982650 [TBL] [Abstract][Full Text] [Related]
18. Novel antigen expression on syngeneic somatic cell hybrids of murine spontaneous mammary tumor cells. Dei T; Masuko K; Ishii H; Makita T; Tachibana T J Natl Cancer Inst; 1986 Aug; 77(2):511-9. PubMed ID: 3461212 [TBL] [Abstract][Full Text] [Related]
19. Selection of a low antigenic variant subline from the TA3St ascites carcinoma by repeated passage of antibody-coated cells through anti-immunoglobulin columns. Dallanis T; Klein G; Andersson B J Natl Cancer Inst; 1979 Aug; 63(2):383-8. PubMed ID: 379399 [TBL] [Abstract][Full Text] [Related]
20. Receptors for immune complexes on cells within a non-lymphoid murine tumor. Braslawsky GR; Yaackubowicz M; Frensdorff A; Witz IP J Immunol; 1976 Jun; 116(6):1571-8. PubMed ID: 1270806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]